Health
Erythropoietin treatment may increase the risk of hip fractures in individuals with kidney failure – News-Medical.Net
Erythropoietin (EPO) is a medication used to stimulate the production of new red blood cells, which is impaired in individuals with kidney failure. Unfortunately,…
Erythropoietin (EPO) is a medication used to stimulate the production of new red blood cells, which is impaired in individuals with kidney failure. Unfortunately, however, the treatment may increase the risk of hip fractures.
In an analysis published in the Journal of Bone and Mineral Research that examined 1997-2013 records from two large U.S. databases, investigators found that EPO doses administered to patients with kidney failure on hemodialysis fluctuated widely over time, and hip fracture…
-
Noosa News24 hours agoQueensland government and nurses and midwives reach in-principle pay deal after months of negotiation
-
Noosa News13 hours agoPill checking to resume in Queensland months after government axed funding
-
Noosa News23 hours agoBrisbane nation’s third-youngest capital; Leaders condemn anti-immigration rally
-
Business16 hours agoWhy Austal, Boss Energy, Harvey Norman, and NextDC shares are charging higher today